Expansion Focus For Asta Medica In 1995

5 May 1996

Asta Medica, part of the German chemical and pharmaceutical group Degussa, focussed on expansion of its activities in 1995, said Rolf Kramer, president and chief executive of the company, in its 1995 annual report. Eight new Asta Medica firms were established in central and eastern Europe, as well as in Asia and Australia.

After the establishment of subsidiaries in the Czech Republic and Hungary, Asta Medica created further companies in Poland, the Slovak Republic, Bulgaria, Romania, Russia and the Ukraine. Subsidiaries were also set up in China, Australia and the Philippines.

The firm is also expanding through collaborations with other drug companies. It has a joint venture with the Japanese firm Nippon Kayaku to develop and market pharmaceutical products in Japan, and it is collaborating with the US biotechnology firm Sugen in the oncology field.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight